QQQ
+ 1.77
429.23
+ 0.41%
BTC/USD
-1289.80
62388.06
-2.0255%
DIA
+ 0.64
381.67
+ 0.17%
SPY
+ 1.33
506.93
+ 0.26%
TLT
+ 0.68
87.56
+ 0.77%
GLD
+ 0.01
216.61
+ 0%

Friends of Benzinga

Fear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Surges 24% In 2023

Fear & Greed Index Remains In ‘Extreme Greed’ Zone; S&P 500 Surges 24% In 2023

The CNN Money Fear and Greed index showed some decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on Friday. U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The index gained for nine consecutive weeks, notching its best winning streak since 2004. read more
Transphorm, Canaan And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

Transphorm, Canaan And Other Big Stocks Moving Higher In Thursday’s Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Thursday. Shares of Transphorm, Inc. (NASDAQ: TGAN) rose sharply in today’s pre-market trading. after Renesas Electronics announced plans to acquire the company for $5.10 per share in cash. read more
Dow Tumbles Over 150 Points; Charles Schwab Posts Upbeat Earnings

Dow Tumbles Over 150 Points; Charles Schwab Posts Upbeat Earnings

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 150 points on Wednesday. The Dow traded down 0.48% to 37,183.10 while the NASDAQ fell 1.15% to 14,772.10. The S&P 500 also fell, dropping, 0.91% to 4,722.52. read more
What's Going On With Phunware Stock Tuesday?

What’s Going On With Phunware Stock Tuesday?

Several Donald Trump-linked stocks are running Tuesday after the former President received roughly 51% of the vote in the Iowa caucus. read more
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday. read more